Free Trial
NASDAQ:RCEL

Avita Medical (RCEL) Stock Price, News & Analysis

Avita Medical logo
$5.47 -0.05 (-0.91%)
Closing price 04:00 PM Eastern
Extended Trading
$5.42 -0.05 (-0.91%)
As of 07:28 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Avita Medical Stock (NASDAQ:RCEL)

Advanced

Key Stats

Today's Range
$5.41
$5.57
50-Day Range
$4.17
$6.76
52-Week Range
$3.60
$14.16
Volume
144,089 shs
Average Volume
1.31 million shs
Market Capitalization
$145.61 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$11.60
Consensus Rating
Hold

Company Overview

Avita Medical Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
39th Percentile Overall Score

RCEL MarketRank™: 

Avita Medical scored higher than 39% of companies evaluated by MarketBeat, and ranked 708th out of 938 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Avita Medical has received a consensus rating of Hold. The company's average rating score is 2.17, and is based on 3 buy ratings, 1 hold rating, and 2 sell ratings.

  • Upside Potential

    Avita Medical has a consensus price target of $11.60, representing about 112.1% upside from its current price of $5.47.

  • Amount of Analyst Coverage

    Avita Medical has only been the subject of 4 research reports in the past 90 days.

  • Read more about Avita Medical's stock forecast and price target.
  • Earnings Growth

    Earnings for Avita Medical are expected to grow in the coming year, from ($0.95) to ($0.04) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Avita Medical is -2.78, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Avita Medical is -2.78, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Avita Medical has a P/B Ratio of 32.18. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Read more about Avita Medical's valuation and earnings.
  • Percentage of Shares Shorted

    18.47% of the float of Avita Medical has been sold short.
  • Short Interest Ratio / Days to Cover

    Avita Medical has a short interest ratio ("days to cover") of 6.7.
  • Change versus previous month

    Short interest in Avita Medical has recently decreased by 1.52%, indicating that investor sentiment is improving.
  • Dividend Yield

    Avita Medical does not currently pay a dividend.

  • Dividend Growth

    Avita Medical does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    18.47% of the float of Avita Medical has been sold short.
  • Short Interest Ratio / Days to Cover

    Avita Medical has a short interest ratio ("days to cover") of 6.7.
  • Change versus previous month

    Short interest in Avita Medical has recently decreased by 1.52%, indicating that investor sentiment is improving.
  • News Coverage This Week

    MarketBeat has tracked 5 news articles for Avita Medical this week, compared to 3 articles on an average week.
  • Search Interest

    Only 1 people have searched for RCEL on MarketBeat in the last 30 days. This is a decrease of -67% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Avita Medical insiders have bought more of their company's stock than they have sold. Specifically, they have bought $113,660.00 in company stock and sold $0.00 in company stock.

  • Percentage Held by Insiders

    Only 2.80% of the stock of Avita Medical is held by insiders.

  • Percentage Held by Institutions

    Only 27.66% of the stock of Avita Medical is held by institutions.

  • Read more about Avita Medical's insider trading history.
Receive RCEL Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Avita Medical and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

RCEL Stock News Headlines

URGENT: The Market's 3 Red Flags Are Flashing
The warning signs that preceded the 2008 crash are reappearing: an irrational NASDAQ bubble, a record-high gold price (signaling fear), and escalating geopolitical risk. A sharp correction might happen tomorrow, and most investors will be caught off guard. Your portfolio is currently exposed.tc pixel
Brokerages Set Avita Medical Inc. (NASDAQ:RCEL) PT at $11.60
See More Headlines

RCEL Stock Analysis - Frequently Asked Questions

Avita Medical's stock was trading at $12.80 at the start of the year. Since then, RCEL stock has decreased by 57.3% and is now trading at $5.47.

Avita Medical Inc. (NASDAQ:RCEL) posted its earnings results on Thursday, August, 7th. The company reported ($0.38) earnings per share for the quarter, missing analysts' consensus estimates of ($0.26) by $0.12. The firm had revenue of $18.42 million for the quarter, compared to analysts' expectations of $34.27 million. Avita Medical had a negative trailing twelve-month return on equity of 632.62% and a negative net margin of 68.87%.
Read the conference call transcript
.

Shares of RCEL stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Avita Medical investors own include Invesco QQQ (QQQ), SPDR S&P 500 ETF Trust (SPY), SPDR Dow Jones Industrial Average ETF Trust (DIA), NVIDIA (NVDA), Meta Platforms (META), Advanced Micro Devices (AMD) and Tesla (TSLA).

Company Calendar

Last Earnings
8/07/2025
Today
10/07/2025
Next Earnings (Estimated)
11/06/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - DRUGS
Sub-Industry
Medical Equipment
Current Symbol
NASDAQ:RCEL
CIK
1762303
Fax
N/A
Employees
130
Year Founded
2008

Price Target and Rating

High Price Target
$21.00
Low Price Target
$3.00
Potential Upside/Downside
+112.8%
Consensus Rating
Hold
Rating Score (0-4)
2.17
Research Coverage
6 Analysts

Profitability

EPS (Trailing Twelve Months)
($1.97)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$61.85 million
Net Margins
-68.87%
Pretax Margin
-68.87%
Return on Equity
-632.62%
Return on Assets
-71.52%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
0.58
Quick Ratio
0.46

Sales & Book Value

Annual Sales
$74.88 million
Price / Sales
1.94
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$0.17 per share
Price / Book
32.06

Miscellaneous

Outstanding Shares
26,619,000
Free Float
25,874,000
Market Cap
$145.07 million
Optionable
Optionable
Beta
1.64

Social Links

10 Best Stocks to Own: Fall 2025 Cover

Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Fall 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report

This page (NASDAQ:RCEL) was last updated on 10/7/2025 by MarketBeat.com Staff
From Our Partners